Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders??? Equity (Unaudited)

v3.20.2
Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 4 $ 195,666 $ (186,857) $ 8,813
Balance (in Shares) at Dec. 31, 2018 3,856,768      
Stock-based compensation 316 316
Stock-based compensation (in Shares) 74      
Issuance of common stock from exercise of warrants 1,504 1,504
Issuance of common stock from exercise of warrants (in Shares) 83,542      
Sale of common stock, net of offering costs 380 380
Sale of common stock, net of offering costs (in Shares) 30,817      
Net loss (5,670) (5,670)
Balance, at Mar. 31, 2019 $ 4 197,866 (192,527) 5,343
Balance, (in Shares) at Mar. 31, 2019 3,971,201      
Stock-based compensation 277   277
Stock-based compensation (in Shares)      
Sale of common stock and warrants, net of offering costs $ 1 15,107   15,108
Sale of common stock and warrants, net of offering costs (in Shares) 1,428,667      
Deemed dividend for warrant down-round protection provision   1 (1)  
Issuance of common stock from exercise of warrants
Issuance of common stock from exercise of warrants (in Shares) 1,249      
Net loss     (5,027) (5,027)
Balance, at Jun. 30, 2019 $ 5 213,251 (197,555) 15,701
Balance, (in Shares) at Jun. 30, 2019 5,401,117      
Stock-based compensation 391 391
Stock-based compensation (in Shares) 13,069      
Sale of common stock and warrants, net of offering costs   444   444
Sale of common stock and warrants, net of offering costs (in Shares) 75,851      
Net loss     (6,600) (6,600)
Balance, at Sep. 30, 2019 $ 5 214,086 (204,155) 9,936
Balance, (in Shares) at Sep. 30, 2019 5,490,037      
Balance at Dec. 31, 2019 $ 5 214,397 (208,758) 5,644
Balance (in Shares) at Dec. 31, 2019 5,490,038      
Stock-based compensation 372 372
Stock-based compensation (in Shares)      
Sale of common stock, net of offering costs $ 1 2,673 2,674
Sale of common stock, net of offering costs (in Shares) 337,944      
Net loss (5,670) (5,670)
Balance, at Mar. 31, 2020 $ 6 217,442 (214,428) 3,020
Balance, (in Shares) at Mar. 31, 2020 5,827,982      
Stock-based compensation 210 210
Stock-based compensation (in Shares) 5,240      
Issuance of common stock from exercise of pre-funded warrants $ 1 3 4
Issuance of common stock from exercise of pre-funded warrants (in Shares) 1,200,000      
Sale of common stock and pre-funded warrants, net of offering costs $ 6 52,159 52,165
Sale of common stock and pre-funded warrants, net of offering costs (in Shares) 6,138,602      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (4,625) (4,625)
Balance, at Jun. 30, 2020 $ 13 269,815 (219,054) 50,774
Balance, (in Shares) at Jun. 30, 2020 13,171,824      
Stock-based compensation 288 288
Stock-based compensation (in Shares) 1,023      
Issuance of common stock from exercise of warrants and stock options   37   37
Issuance of common stock from exercise of warrants and stock options (in Shares) 2,609      
Issuance of common stock from exercise of pre-funded warrants $ 1 1   2
Issuance of common stock from exercise of pre-funded warrants (in Shares) 411,069      
Costs related to prospectus filed on Form S-3   (134)   (134)
Net loss     (5,540) (5,540)
Balance, at Sep. 30, 2020 $ 14 $ 270,007 $ (224,594) $ 45,427
Balance, (in Shares) at Sep. 30, 2020 13,586,525